Wilderotter Mary Agnes

SEC source: 0001261333-19-000063 · wf-form4_156097728833616.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,689

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs will vest in equal quarterly installments over one year, with a vesting commencement date of June 17, 2019, in each case subject to the reporting person being a service provider through each such date.

SEC source: 0001209191-19-036755 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,039

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs shall vest on each of August 20, 2019, November 20, 2019, February 20, 2020, and the earlier of May 20, 2020 or the day prior to the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.

F2 · balance_after: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001179706-19-000085 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,125

Underlying: Common Stock · 14,125 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · price: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.exercise_date: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.expiration_date: On 05/03/19, the reporting person was granted 14,125 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/03/20 or the date of Issuer's 2020 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001179706-19-000060 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,777 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18, and 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19.

F4 · shares: The number of derivative securities in column 5 includes 284 vested dividend equivalent rights and a de minimus adjustment of 0.5175 due to fractional rounding of the dividend equivalent rights.

F3 · price: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18, and 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19.

F3 · derivative.exercise_date: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18, and 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19.

F3 · derivative.expiration_date: As previously reported, on 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 95.1566 dividend equivalent rights at $14.77 per RSU credited to the reporting person's account on 07/04/18, 83.9082 dividend equivalent rights at $16.75 per RSU credited to the reporting person's account on 10/03/18, and 104.4177 dividend equivalent rights at $13.46 per RSU credited to the reporting person's account on 01/02/19.

SEC source: 0001179706-19-000060 · edgar.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,693

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The number of shares in column 5 includes 66 vested restricted stock unit ("RSU") dividend equivalent rights at $17.25 per RSU credited to the reporting person's account on 04/04/18.

SEC source: 0000899243-19-010045 · doc4.xml · nonDerivative · entry 3

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,562

F3 · shares: Represents shares acquired pursuant to a directed share program in connection with the Issuer's initial public offering of Class A Common Stock.

F4 · balance_after: Certain of these securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

SEC source: 0000899243-19-010045 · doc4.xml · nonDerivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,062

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F2 · balance_after: These securities are restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

SEC source: 0000899243-19-010045 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.

SEC source: 0001209191-19-013421 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,823

F1 · shares: Incentive stock award fully vests on February 22, 2020.

SEC source: 0001209191-18-056098 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,305

F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2019, and one-third annually on October 22 for the following two years.

F2 · price: Not applicable. Grant of Restricted Stock Units.

SEC source: 0001179706-18-000104 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,493

Underlying: Common Stock · 12,493 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · price: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.exercise_date: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.expiration_date: On 05/04/18, the reporting person was granted 12,493 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/04/19 or the date of Issuer's 2019 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001179706-18-000072 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,351 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As reported in the Registration Statements on Form 10 filed by Issuer with the SEC, in connection with the spin-offs of Everett SpinCo, Inc. on 04/01/17 and Seattle SpinCo, Inc. on 09/01/17, equity-based awards granted by Issuer, prior to the spin-offs were converted to adjust the award in a manner intended to preserve the aggregate intrinsic value of the original award as measured immediately before and immediately after the spin-offs, subject to rounding. The adjusted equity award is otherwise subject to the same terms and conditions that applied to the original award immediately prior to the spin-offs, unless otherwise noted. The reporting person's equity based awards reflect the conversion adjustments.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (1) above.

F4 · shares: The number of derivative securities in column 5 includes 201.9541 vested dividend equivalent rights and a de minimus adjustment of 0.0459 due to fractional rounding of the dividend equivalent rights.

F3 · price: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (1) above.

F3 · derivative.exercise_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (1) above.

F3 · derivative.expiration_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The 201.9541 dividend equivalent rights being reported reflect 45.4808 dividend equivalent rights at $16.94 per RSU credited to the reporting person's account on 07/05/17, 66.5328 dividend equivalent rights at $14.80 per RSU credited to the reporting person's account on 10/04/17, and 77.2908 dividend equivalent rights at $14.70 per RSU credited to the reporting person's account on 01/03/18. Vested RSUs in this footnote, and the amount in column 9 reflect the conversion adjustments noted in footnote (1) above.

SEC source: 0001179706-18-000072 · edgar.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-017831 · doc4.xml · derivative · entry 4

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2027-06-15

F1 · date: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.

F2 · price: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

F2 · derivative.exercise_date: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

SEC source: 0001209191-18-017831 · doc4.xml · derivative · entry 3

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2026-06-16

F1 · date: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.

F2 · price: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

F2 · derivative.exercise_date: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

SEC source: 0001209191-18-017831 · doc4.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2025-06-11

F1 · date: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.

F2 · price: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

F2 · derivative.exercise_date: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

SEC source: 0001209191-18-017831 · doc4.xml · derivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,000 shares

Expires 2024-11-03

F1 · date: On January 21, 2018, Juno Therapeutics, Inc. (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with Celgene Corporation ("Parent"), and Blue Magpie Corporation, a wholly owned subsidiary of Parent ("Purchaser"). On March 5, 2018, Purchaser irrevocably accepted for payment and promptly paid for, all shares of common stock validly tendered and not validly withdrawn pursuant to the Offer (as defined in the Merger Agreement). On March 6, 2018, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation (the "Merger") and becoming a wholly-owned subsidiary of Parent.

F2 · price: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

F2 · derivative.exercise_date: In accordance with their terms, Options held by non-employee directors were converted into the right to receive an amount in cash equal to the product of (i) the number of shares of common stock subject to such Option and (ii) $87.00 less the applicable exercise price.

SEC source: 0001209191-18-008823 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,464

F1 · shares: Incentive stock award fully vests on February 7, 2019.

SEC source: 0001209191-17-057895 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,316

F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2018, and one-third annually on October 22 for the following two years.

F2 · price: Not applicable. Grant of Restricted Stock Units.

SEC source: 0001209191-17-058194 · doc4a.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,126

F1 · shares: Reported incorrect number of shares in previous filing.

F2 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2018, and one-third annually on October 22 for the following two years.

F3 · price: Not applicable. Grant of Restricted Stock Units.

SEC source: 0001209191-17-042685 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,538

F1 · shares: Incentive stock award fully vests on February 21, 2018.

SEC source: 0001209191-17-040854 · doc4.xml · derivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-15

F1 · derivative.exercise_date: 100% of the shares subject to the option become vested and exercisable on the earlier of (i) the date of the 2018 Annual Meeting of Stockholders and (ii) the first anniversary of the grant date, in either event, subject to the director continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through such date.

SEC source: 0001209191-17-035655 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,446

F1 · shares: Represents additional restricted stock units ("RSUs") resulting from the upward adjustment of outstanding unvested RSUs by a factor of 1.032, in connection with the special cash dividend to be paid by the issuer on May 26, 2017. The adjustment was required under applicable plan documents. The additional RSUs reported are subject to the same vesting schedules as the original unvested RSUs to which they relate.

SEC source: 0001179706-17-000116 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,853

Underlying: Common Stock · 11,853 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F3 · shares: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · price: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.exercise_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · derivative.expiration_date: On 04/21/17 the reporting person was granted 11,853 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 04/21/18 or the date of Issuer's 2018 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001179706-17-000058 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,253 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16; 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16; and 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

F3 · shares: The number of derivative securities in column 5 includes 84 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F2 · price: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16; 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16; and 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

F2 · derivative.exercise_date: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16; 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16; and 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

F2 · derivative.expiration_date: On 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested is an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16; 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16; and 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17.

SEC source: 0001179706-17-000058 · edgar.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001179706-17-000115 · edgar.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,499 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F3 · shares: The number of derivative securities in column 5 includes 30.3965 dividend equivalent rights at $18.40 per RSU credited to the reporting person's account on 07/06/16; 24.8907 dividend equivalent rights at $22.47 per RSU credited to the reporting person's account on 10/31/16; and 28.1870 dividend equivalent rights at $23.45 per RSU credited to the reporting person's account on 01/04/17. The number of derivative securities in column 5 includes 110 vested dividend equivalent rights and a de minimus adjustment of 0.5258 due to fractional rounding of the dividend equivalent rights.

F2 · price: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.exercise_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

F2 · derivative.expiration_date: As previously reported, on 04/25/16 the reporting person was granted 10,169 restricted stock units ("RSUs"), all of which cliff vested on the earlier of 04/25/17 or the date of Issuer's 2017 Annual Stockholders Meeting. The number of RSUs that vested was an estimated amount, subject to change due to the vesting triggered during the Issuer's ex-dividend trading period prior to its spin-off of Everett SpinCo, Inc. on 04/01/17. The number of RSUs reported in this amendment reflects that conversion adjustment. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.

SEC source: 0001179706-17-000115 · edgar.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-16-146704 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,332

F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2017, and one-third annually on October 22 for the following two years.

F2 · price: Not applicable. Grant of Restricted Stock Units.

SEC source: 0001209191-15-076811 · doc4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,150

F1 · shares: Grant of Restricted Stock Units. Vests one-third on October 22, 2016, and one-third annually on October 22 for the following two years.

F2 · price: Not applicable. Grant of Restricted Stock Units.

SEC source: 0001127602-14-031001 · form4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,136.094

F1 · price: Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan

F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs.

SEC source: 0001127602-13-029162 · form4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,649.443

F1 · price: Stock Units awarded pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on November 15, 2012, February 15, 2013, May 15, 2013 and August 15, 2013, pursuant to issuer's 2003 Non-Employee Directors' Stock Plan.

SEC source: 0001127602-12-028585 · form4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,043.957

F1 · price: Stock Units awarded pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on November 15, 2011, February 15, 2012, May 15, 2012 and August 15, 2012, pursuant to issuer's 2003 Non-Employee Directors' Stock Plan.

SEC source: 0001127602-11-027251 · form4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,461.024

F1 · price: Stock Units awarded pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs on November 15, 2010, February 15, 2011, May 16, 2011 and August 15, 2011, pursuant to issuer's 2003 Non-Employee Directors' Stock Plan.

SEC source: 0001127602-10-025441 · form4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,829.789

F1 · price: Restricted Stock Units (RSUs) awarded pursuant to Issuer's 2003 Non-Employee Directors' Stock Plan.

F2 · balance_after: Total includes grant of dividend equivalents in the form of RSUs since November 16, 2009, pursuant to issuer's 2003 Non-Employee Directors' Stock Plan.

SEC source: 0001127602-09-020717 · form4.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,184

F1 · price: Shares received pursuant to the 2003 Non-Employee Directors' Stock Plan.

SEC source: 0001127602-09-025186 · form4a.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,184

F1 · shares: This amendment is being filed solely to add the written authorization. The line item is being re-reported to gain access to the filing system.